Media Releases

2018

17/10/2018

Proteomics receives $834k in R&D Tax Incentive

05/10/2018

Proteomics receives $928k from sale of shareholding in CPR

19/09/2018

Proteomics & Atturos partner to target diagnostics in Europe

18/09/2018

Proactive Investors Australia – Proteomics International Laboratories boosts balance sheet with sale of CPR Pharma Services stake

12/09/2018

Proteomics to receive $928k from sale of shareholding in CPR

08/09/2018

The Australian Financial Review – PromarkerD Australian-developed blood test could help for 30 million diabetics

07/09/2018

The Australian – Australian-developed blood test could help 30 million American diabetics

07/09/2018

SBS News – Diabetes sufferers could soon predict whether their kidney will deteriorate following an Australian company’s launch of a diagnostic test in the US market.

23/08/2018

Diagnostics Update – the Promarker pipeline

03/08/2018

Proteomics on Bulls, Bears & Brokers

17/07/2018

Proteomics secures major contract – nears cash flow positive

22/06/2018

Proteomics at ADA Diabetes Conference

20/06/2018

Proteomics signs deal with Patia for PromarkerD in Mexico

30/05/2018

Australian R&D Tax Incentive Customer Stories – Proteomics International- Saving lives through new predictive diagnostic tests

29/05/2018

MTP Connect – Proteomics International signs deal with PrismHealthDx to launch PromarkerD predictive test for diabetic kidney disease in USA

1
…
16
17
18
19
20
21
22
…
27